MedPath

Comparison of blood transfusion in patient received tranexamic acid in femoral shaft fracture who operated with plate and screw fixation, randomized control trial.

Phase 2
Recruiting
Conditions
Perioperative bleeding in femoral shaft fracture patient, operated with plate and screw fixation.
tranexamic acid, femoral shaft fracture, femur fracture, ORIF, plate and screw, blood transfusion
Registration Number
TCTR20220701003
Lead Sponsor
Khon Kaen Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
102
Inclusion Criteria

1.Age > 18 years old 2.Unilateral Femoral shaft fracture (AO classification type A,B) 3.Operated with ORIF with plate and screw

Exclusion Criteria

1.Associated with hemothorax, intra-abdominal bleeding or pelvic fracture
2.Receive more than one operation during admission
3.Contraindicated in tranexamic acid: TXA allergy, acquired defective color vision ,subarachnoid hemorrhage, history of venous or arterial occlusion disease
4.Pregnancy
5.Underlying disease with dependent transfusion
6.Currently using antifibrinolytic or anticoagulant medications

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
unit of packed red cell transfusion until discharge unit
Secondary Outcome Measures
NameTimeMethod
Hemoglobin level post op 24 h until discharge g/dL,adverse event of tranexamic acid (Deep vein thrombosis, Pulmonary Embolism, allergy) until discharge event
© Copyright 2025. All Rights Reserved by MedPath